Apollo Healthcare Corp. (AHC.TO) P/E Ratio
As of May 22, 2026
TL;DR — AHC.TO P/E ratio is 4.2x
Apollo Healthcare Corp. (AHC.TO) currently trades at a trailing P/E of 4.2x (cheap (deep value)). Forward P/E is estimated at 3.8x. The implied earnings yield is 24.10%. Trading below 10x earnings is the historical deep-value zone. Often signals either a genuine bargain or that earnings are about to fall — verify with cash flow and the Quality Triple Check.
Trailing P/E vs Forward P/E
Trailing P/E (TTM)
4.2x
Based on last 12 months of reported EPS
Forward P/E (est)
3.8x
Estimated next 12 months
PEG
N/A
P/E divided by EPS growth — under 1 = cheap
Trailing P/E uses the last 12 months of actual reported earnings — it is the most reliable number because the inputs have already happened. Forward P/E uses consensus analyst estimates for the next 12 months — useful for fast-growing companies whose past earnings understate their future, but vulnerable to estimate revisions. The PEG ratio (P/E divided by earnings growth) is the bridge: a PEG below 1.0 traditionally signals you're paying less per share than the business is growing per share.
10-Year Historical P/E
Over the past decade, AHC.TO has traded at a median P/E of roughly 4.2x. Today's reading of 4.2x is roughly in line with its own historical median. This is a useful relative anchor: paying less than the long-run average implies either a buying opportunity or a structural worry that the market has correctly priced in.
Series illustrated from current P/E. Full 10-year monthly history ships in the upcoming valuation-data ingest.
Industry Comparison
The Consumer Defensive sector median P/E is roughly 19x. AHC.TO at 4.2x is currently ~78% below the sector — either a value opportunity or a sign of structural concerns the market has priced in..
Compare AHC.TO against every other Consumer Defensive stock in the full sector list.
Interpreting AHC.TO's P/E
What "Cheap (deep value)" means here: Trading below 10x earnings is the historical deep-value zone. Often signals either a genuine bargain or that earnings are about to fall — verify with cash flow and the Quality Triple Check.
Decision rule: a low P/E by itself is not a buy signal. Always check the cash flow statement, the Quality Triple Check (Piotroski / Beneish / Altman) from the fundamentals page, and the intrinsic value (DCF margin of safety) before acting on a multiple alone.
Common pitfalls: trailing P/E can be flattered by one-off tax benefits, share buybacks, or asset sales. Forward P/E can be overstated by overly optimistic analyst estimates. Read at least two of the most recent quarterly earnings calls before treating either as truth.
Related AHC.TO analyses
Frequently asked about AHC.TO P/E
What is AHC.TO's current P/E ratio?↓
AHC.TO's trailing P/E ratio is 4.2x as of May 22, 2026, which we classify as "Cheap (deep value)". Trading below 10x earnings is the historical deep-value zone. Often signals either a genuine bargain or that earnings are about to fall — verify with cash flow and the Quality Triple Check.
Is AHC.TO's P/E ratio cheap or expensive?↓
Against the Consumer Defensive sector median of ~19x, AHC.TO's 4.2x is materially below the sector — a discount of about 78%, which is either a real bargain or signals an earnings risk worth investigating.
What is the difference between trailing and forward P/E?↓
Trailing P/E (TTM) uses the last 12 months of actual earnings — backward-looking but reliable. Forward P/E uses consensus analyst estimates for the next 12 months — more useful for growth stories but vulnerable to estimate revisions. Most value investors anchor on trailing P/E and use forward P/E as a sanity check.
How is P/E related to earnings yield?↓
Earnings yield = 1 / P/E. For AHC.TO at 4.2x P/E, earnings yield is roughly 24.10%. This is comparable to a bond yield: it tells you the "earnings return" you'd get if you bought the whole company at this price.
When is P/E the wrong metric to use?↓
P/E breaks down for companies with negative earnings, heavy non-cash items, one-off events (restructuring, write-downs, tax benefits), banks (where book value and P/B are more appropriate), and high-CapEx commodity businesses (where EV/EBITDA is more comparable). Always cross-check P/E with at least one other valuation lens.